Interleukin 12 levels during the initial phase of septic shock with purpura in children: Relation to severity of disease

Cytokine

Volumn 9, Issue 9, 1997, Pages 711-716

  Hazelzet, Jan A ^a,b   Kornelisse, René F ^b   Van Der Pouw Kraan, Tineke C T M ^c   Joosten, Koen F M ^a   Van Der Voort, Edwin ^a   Van Mierlo, Gerard ^c   Suur, Marja H ^b   Hop, Wim C J ^a   De Groot, Ronald ^b   Hack, C Erik ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Interleukin 12; Meningococcal infections; Purpura; Septic shock; T lymphocytes

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; POLYPEPTIDE; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFANT; LACTATE BLOOD LEVEL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURPURA; SCHOOL CHILD; SEPTIC SHOCK;

PURPURA;

EID: 0031239627     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0215     Document Type: Article

References (40)

1. 1. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169:333-338.
2. 2. Hazelzet JA, Van der Voort E, Lindemans J, Heerdt PGJT, Neijens HJ (1994) Relation between cytokines and routine laboratory data in children with septic shock and purpura. Int Care Med 20:371-374.
3. 3. Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A (1993) Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 167:471-475.
4. 4. Derkx B, Marchant A, Goldman M, Bijlmer R, Deventer SV (1995) High levels of interleukin 10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 171:229-232.
5. 5. Kornelisse RF, Hazelzet JA, Savelkoul HFJ, Hop WCJ, Suur MH, Borsboom ANJ, Risseeuw-Appel IM, van der Voort E, de Groot R (1996) The relation between plasminogen activator inhibitor-1, proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Inf Dis 173:1148-1156.
6. 6. Brandtzaeg P, Sandset PM, Joo GB, Ovstebo R, Abildgaard U, Kierulf P (1989) The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 55:459-470.
7. 7. Kobayashi M, Fitz L, Ryan M, Hewisk R, Clark S, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170:827.
8. 8. Trinchieri G (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
9. 9. Trinchieri G, Kubin M, Bellone G, Cassatella MA (1993) Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J Cell Biochem 53:301-308.
10. 10. Chehimi J, Trinchieri G (1994) Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 14:149-161.
11. 11. Trinchieri G, Wysocka M, D'Andréa A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J (1992) Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 4:355-368.
12. 12. Trinchieri G (1993) Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14:335-338.
13. 13. Zeh H, Tahara H, Lotze M (1994) Interleukin-12, The cytokine handbook. (2nd edn). Academic Press Ltd., pp. 239-256.
14. 14. Trinchieri G, Scott P (1994) The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 15:460-463.
15. 15. Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, Sadick MD (1991) Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Res Immunol 142:28-32.
16. 16. Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS (1994) Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun 62:4244-4249.
17. 17. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G (1995) Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 25:672-676.
18. 18. Heinzel FP (1990) The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 145: 2920-2924.
19. 19. Bucklin SE, Russell SW, Morrison DC (1994) Participation of IFN-gamma in the pathogenesis of LPS lethality. Prog Clin Biol Res 388:399-406.
20. 20. Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner JD, Glauser MP (1993) IFN-gamma involvement in the severity of gram-negative infections in mice. J Immunol 151:916-921.
21. 21. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397-400.
22. 22. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 161:982-987.
23. 23. Jansen P, van der Pouw Kraan T, de Jong I, van Mierlo G, Wijdenes J, Chang A, Taylor F, Hack C (1996) Release of interleukin 12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin 10 and interferon-γ (gamma). Blood 87:5144-5151.
24. 24. Ozmen L, Pericin M, Hakimi J, Chizzonite RA, Wysocka M, Trinchieri G, Gately M, Garotta G (1994) Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med 180:907-915.
25. 25. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf S, Trinchieri G (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398.
26. 26. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G (1995) Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 25:1-5.
27. 27. Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rude E, Germann T (1993) The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 23:2202-2208.
28. 28. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC Hakimi Y (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biological activity. J Immunol 154:116-127.
29. 29. Germann T, Rude E (1995) Interleukin-12. Int Arch Allergy Immunol 108:103-112.
30. 30. D'Andrea A, Aste-Amezaga M, Valiante N, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 inhibits human lymphocyte interferon-j production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048.
31. 31. Gazzinelli RT, Hayashi S, Wysocka M, Carrera L, Kuhn R, Muller W, Roberge F, Trinchieri G, Sher A (1994) Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J Eukaryot Microbiol 41:95.
32. 32. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195-204.
33. 33. Billiau A, Heremans H, Vandekerckhove F, Dillen C (1987) Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction. Eur J Immunol 17:1851-1854.
34. 34. Billiau A (1988) Gamma-interferon: the match that lights the fire? Immunol Today 9:37-40.
35. 35. Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110-1116.
36. 36. Leclerc F, Beuscart R, Guillois B, Diependaele F, Krim G, Devictor D, Bompard Y, van Albada T (1985) Prognostic factors of severe infectious purpura in children. Intensive Care Med 11:140-143.
37. 37. Leclerc F, Chenaud M, Delepoulle F, Francois DJ, Alain M, Valerie H (1991) Prognostic value of C-reactive protein level in severe infectious purpura: a comparison with eight other scores. Crit Care Med 19:430-432.
38. 38. Emparanza J, Aldamiz-Echevaria L, Rerez-Yarza E (1988) Prognostic score in acute meningococcemia. Crit Care Med 16:168-169.
39. 39. Sternberg J (1977) A rate nephelometer for measuring specific proteins by immunoprecipitation reaction. Clin Chem 23:1456-1464.
40. 40. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181:775-779.